BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16342942)

  • 1. Computational studies of the farnesyltransferase ternary complex part I: substrate binding.
    Cui G; Wang B; Merz KM
    Biochemistry; 2005 Dec; 44(50):16513-23. PubMed ID: 16342942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulations on the critical states of the farnesyltransferase enzyme.
    Sousa SF; Fernandes PA; Ramos MJ
    Bioorg Med Chem; 2009 May; 17(9):3369-78. PubMed ID: 19369081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation.
    Pickett JS; Bowers KE; Hartman HL; Fu HW; Embry AC; Casey PJ; Fierke CA
    Biochemistry; 2003 Aug; 42(32):9741-8. PubMed ID: 12911316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding a needle in the haystack: computational modeling of Mg2+ binding in the active site of protein farnesyltransferase.
    Yang Y; Chakravorty DK; Merz KM
    Biochemistry; 2010 Nov; 49(44):9658-66. PubMed ID: 20923173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics.
    Long SB; Hancock PJ; Kral AM; Hellinga HW; Beese LS
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12948-53. PubMed ID: 11687658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme flexibility and the catalytic mechanism of farnesyltransferase: targeting the relation.
    Sousa SF; Fernandes PA; Ramos MJ
    J Phys Chem B; 2008 Jul; 112(29):8681-91. PubMed ID: 18572907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate.
    Long SB; Casey PJ; Beese LS
    Biochemistry; 1998 Jul; 37(27):9612-8. PubMed ID: 9657673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the alpha-secondary kinetic isotope effect for the reaction catalyzed by mammalian protein farnesyltransferase.
    Pais JE; Bowers KE; Fierke CA
    J Am Chem Soc; 2006 Nov; 128(47):15086-7. PubMed ID: 17117849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positively charged side chains in protein farnesyltransferase enhance catalysis by stabilizing the formation of the diphosphate leaving group.
    Bowers KE; Fierke CA
    Biochemistry; 2004 May; 43(18):5256-65. PubMed ID: 15122891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein farnesyl transferase target selectivity is dependent upon peptide stimulated product release.
    Troutman JM; Andres DA; Spielmann HP
    Biochemistry; 2007 Oct; 46(40):11299-309. PubMed ID: 17877368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational studies of the farnesyltransferase ternary complex part II: the conformational activation of farnesyldiphosphate.
    Cui G; Merz KM
    Biochemistry; 2007 Oct; 46(43):12375-81. PubMed ID: 17918965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of protein farnesyltransferase to a geranylgeranyltransferase.
    Terry KL; Casey PJ; Beese LS
    Biochemistry; 2006 Aug; 45(32):9746-55. PubMed ID: 16893176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical studies on farnesyltransferase: the distances paradox explained.
    Sousa SF; Fernandes PA; Ramos MJ
    Proteins; 2007 Jan; 66(1):205-18. PubMed ID: 17068802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of isoprenoid and peptide substrate specificity in protein farnesyltransferase.
    Reigard SA; Zahn TJ; Haworth KB; Hicks KA; Fierke CA; Gibbs RA
    Biochemistry; 2005 Aug; 44(33):11214-23. PubMed ID: 16101305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem.
    Sousa SF; Fernandes PA; Ramos MJ
    Curr Med Chem; 2008; 15(15):1478-92. PubMed ID: 18537624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational and conformational evaluation of FTase alternative substrates: insight into a novel enzyme binding pocket.
    Henriksen BS; Zahn TJ; Evanseck JD; Firestine SM; Gibbs RA
    J Chem Inf Model; 2005; 45(4):1047-52. PubMed ID: 16045300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release.
    Furfine ES; Leban JJ; Landavazo A; Moomaw JF; Casey PJ
    Biochemistry; 1995 May; 34(20):6857-62. PubMed ID: 7756316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective modification of CaaX peptides with ortho-substituted anilinogeranyl lipids by protein farnesyl transferase: competitive substrates and potent inhibitors from a library of farnesyl diphosphate analogues.
    Troutman JM; Subramanian T; Andres DA; Spielmann HP
    Biochemistry; 2007 Oct; 46(40):11310-21. PubMed ID: 17854205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein farnesyltransferase isoprenoid substrate discrimination is dependent on isoprene double bonds and branched methyl groups.
    Micali E; Chehade KA; Isaacs RJ; Andres DA; Spielmann HP
    Biochemistry; 2001 Oct; 40(41):12254-65. PubMed ID: 11591144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of the fungal pathogen Aspergillus fumigatus protein farnesyltransferase complexed with substrates and inhibitors reveal features for antifungal drug design.
    Mabanglo MF; Hast MA; Lubock NB; Hellinga HW; Beese LS
    Protein Sci; 2014 Mar; 23(3):289-301. PubMed ID: 24347326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.